| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 8:07 PM View:  | Reznick Yehuda Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-24 | Grant | 29,800 | -- | -- | 100% 0 to 29.8K | |
| 30-Jan-24 5:30 PM View: | Aghion Daniel Director | Oramed Pharmaceuticals Inc. (ORMP) | 30-Jan-24 | Grant | 3,750 | -- | -- | 11% 35.07K to 38.82K | |
| 08-Jan-24 4:36 PM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 38,820 | -- | -- | 33% 116.5K to 155.32K | |
| 08-Jan-24 4:37 PM View: | Sank Leonard Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 39,325 | -- | -- | 67% 58.7K to 98.02K | |
| 08-Jan-24 4:43 PM View: | Kidron Miriam Chief Scientific Officer Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 295,500 | -- | -- | 63% 468.17K to 763.67K | |
| 08-Jan-24 4:32 PM View: | Shapiro Benjamin Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 35,070 | -- | -- | 2% 1.92M to 1.96M | |
| 08-Jan-24 4:41 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 329,000 | -- | -- | 21% 1.58M to 1.91M | |
| 08-Jan-24 4:40 PM View: | Hexter Joshua COO & CBO | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 180,500 | -- | -- | 60% 301.33K to 481.83K | |
| 08-Jan-24 4:34 PM View: | Mayer Arie Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 39,325 | -- | -- | 69% 56.81K to 96.13K | |
| 08-Jan-24 4:33 PM View: | Aghion Daniel Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 35,070 | -- | -- | 100% 0 to 35.07K | |
| 08-Jan-24 4:39 PM View: | Silberman David Chief Financial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 04-Jan-24 | Grant | 136,500 | -- | -- | 59% 230.0K to 366.5K | |
| 31-May-23 5:10 PM View: | Derovan Netanel Chief Legal Officer | Oramed Pharmaceuticals Inc. (ORMP) | 26-May-23 | Grant | 20,500 | -- | -- | 16% 129.0K to 149.5K | |
| 31-May-23 5:10 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 26-May-23 | Grant | 120,000 | -- | -- | 8% 1.46M to 1.58M | |
| 31-May-23 5:10 PM View: | Hexter Joshua COO & CBO | Oramed Pharmaceuticals Inc. (ORMP) | 26-May-23 | Grant | 27,000 | -- | -- | 10% 274.33K to 301.33K | |
| 31-May-23 5:10 PM View: | Silberman David Chief Financial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 26-May-23 | Grant | 24,500 | -- | -- | 12% 205.5K to 230.0K | |
| 31-May-23 5:10 PM View: | Kidron Miriam Chief Scientific Officer Director | Oramed Pharmaceuticals Inc. (ORMP) | 26-May-23 | Grant | 53,500 | -- | -- | 13% 414.67K to 468.17K | |
| 01-May-23 5:12 PM View: | Shapiro Benjamin Director | Oramed Pharmaceuticals Inc. (ORMP) | 01-May-23 | Grant | 20,000 | -- | -- | 1% 1.9M to 1.92M | |
| 20-Apr-23 6:00 AM View: | Hexter Joshua COO & CBO | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 108,000 | -- | -- | 65% 166.33K to 274.33K | |
| 20-Apr-23 6:00 AM View: | Silberman David Chief Financial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 97,500 | -- | -- | 90% 108.0K to 205.5K | |
| 20-Apr-23 6:00 AM View: | Mayer Arie Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 30,000 | -- | -- | 112% 26.81K to 56.81K | |
| 20-Apr-23 6:00 AM View: | Kidron Miriam Chief Scientific Officer Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 213,000 | -- | -- | 106% 201.67K to 414.67K | |
| 20-Apr-23 6:00 AM View: | Derovan Netanel Chief Legal Officer | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 81,000 | -- | -- | 169% 48.0K to 129.0K | |
| 20-Apr-23 6:00 AM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 30,000 | -- | -- | 35% 86.5K to 116.5K | |
| 20-Apr-23 6:00 AM View: | Sank Leonard Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 30,000 | -- | -- | 105% 28.7K to 58.7K | |
| 20-Apr-23 6:00 AM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Apr-23 | Grant | 279,000 | -- | -- | 24% 1.18M to 1.46M | |
| 04-Apr-23 5:10 PM View: | Mayer Arie Director | Oramed Pharmaceuticals Inc. (ORMP) | 04-Apr-23 | Purchase | 3,800 | $2.21 | $8,398.00 | 17% 23.01K to 26.81K | |
| 04-Apr-23 5:10 PM View: | Mayer Arie Director | Oramed Pharmaceuticals Inc. (ORMP) | 03-Apr-23 | Private Purchase | 5,009 | $2.22 | $11,120.00 | 28% 18.0K to 23.01K | |
| 16-Mar-23 10:00 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 16-Mar-23 | Private Purchase | 26,000 | $2.04 | $53,014.00 | 2% 1.15M to 1.18M | |
| 15-Mar-23 5:25 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 14-Mar-23 | Private Purchase | 100,000 | $2.01 | $201,000.00 | 9% 1.05M to 1.15M | |
| 15-Mar-23 5:20 PM View: | Kidron Miriam Chief Scientific Officer Director | Oramed Pharmaceuticals Inc. (ORMP) | 14-Mar-23 | Sale | 100,000 | $2.01 | $201,000.00 | (33%) 301.67K to 201.67K | |
| 15-Mar-23 5:15 PM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 14-Mar-23 | Purchase | 50,000 | $2.05 | $102,450.00 | 137% 36.5K to 86.5K | |
| 15-Mar-23 5:15 PM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 13-Mar-23 | Private Purchase | 20,000 | $1.96 | $39,120.00 | 121% 16.5K to 36.5K | |
| 04-Jan-23 7:24 AM View: | Rabinowitz Michael Chief Commercial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 03-Jan-23 | Market Sale | 13,325 | $12.55 | $167,195.00 | (10%) 139.47K to 126.14K | 4% |
| 28-Oct-22 9:30 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 27-Oct-22 | Gift | 25,000 | -- | -- | (2%) 1.08M to 1.05M | |
| 10-Aug-22 4:30 PM View: | Sank Leonard Director | Oramed Pharmaceuticals Inc. (ORMP) | 08-Aug-22 | Payment of Exercise | 9,304 | $8.77 | $81,596.10 | (24%) 38.0K to 28.7K | |
| 10-Aug-22 4:30 PM View: | Sank Leonard Director | Oramed Pharmaceuticals Inc. (ORMP) | 08-Aug-22 | Option Exercise | 20,000 | $4.08 | $81,600.00 | 111% 18.0K to 38.0K | |
| 01-Aug-22 8:00 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 01-Aug-22 | Payment of Exercise | 12,631 | $8.36 | $105,595.00 | (1%) 1.09M to 1.08M | |
| 01-Aug-22 8:01 PM View: | Mayer Arie Director | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 12,000 | -- | -- | 200% 6.0K to 18.0K | |
| 01-Aug-22 8:00 PM View: | Kidron Nadav President and CEO Director | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 160,000 | -- | -- | 17% 930.73K to 1.09M | |
| 01-Aug-22 8:00 PM View: | Derovan Netanel Chief Legal Officer | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 30,000 | -- | -- | 167% 18.0K to 48.0K | |
| 01-Aug-22 8:00 PM View: | Rabinowitz Michael Chief Commercial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 30,000 | -- | -- | 27% 109.47K to 139.47K | |
| 01-Aug-22 8:00 PM View: | Hexter Joshua COO & CBO | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 42,000 | -- | -- | 34% 124.33K to 166.33K | |
| 01-Aug-22 8:01 PM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 12,000 | -- | -- | 267% 4.5K to 16.5K | |
| 01-Aug-22 8:00 PM View: | Sank Leonard Director | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 12,000 | -- | -- | 200% 6.0K to 18.0K | |
| 01-Aug-22 8:00 PM View: | Silberman David Chief Financial Officer | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 39,000 | -- | -- | 57% 69.0K to 108.0K | |
| 01-Aug-22 8:00 PM View: | Kidron Miriam Chief Scientific Officer Director | Oramed Pharmaceuticals Inc. (ORMP) | 28-Jul-22 | Grant | 118,000 | -- | -- | 64% 183.67K to 301.67K | |
| 03-May-22 5:30 PM View: | Rozov Yadin Director | Oramed Pharmaceuticals Inc. (ORMP) | 02-May-22 | Grant | 4,500 | -- | -- | 100% 0 to 4.5K | |
| 22-Mar-22 8:30 PM View: | Rakin Kevin Director | Oramed Pharmaceuticals Inc. (ORMP) | 21-Mar-22 | Sale | 10,000 | $9.41 | $94,096.00 | (18%) 56.66K to 46.66K | |
| 22-Feb-22 5:30 PM View: | Rakin Kevin Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Feb-22 | Payment of Exercise | 3,010 | $10.63 | $31,996.30 | (5%) 59.67K to 56.66K | |
| 22-Feb-22 5:30 PM View: | Rakin Kevin Director | Oramed Pharmaceuticals Inc. (ORMP) | 17-Feb-22 | Option Exercise | 6,667 | $4.80 | $32,001.60 | 13% 53.0K to 59.67K |
